Cargando…
IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354603/ https://www.ncbi.nlm.nih.gov/pubmed/35935853 http://dx.doi.org/10.3389/fphar.2022.947363 |
| _version_ | 1784763108406853632 |
|---|---|
| author | Xi, Yufeng Wang, Yujia |
| author_facet | Xi, Yufeng Wang, Yujia |
| author_sort | Xi, Yufeng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9354603 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93546032022-08-06 IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? Xi, Yufeng Wang, Yujia Front Pharmacol Pharmacology Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9354603/ /pubmed/35935853 http://dx.doi.org/10.3389/fphar.2022.947363 Text en Copyright © 2022 Xi and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Xi, Yufeng Wang, Yujia IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? |
| title | IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? |
| title_full | IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? |
| title_fullStr | IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? |
| title_full_unstemmed | IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? |
| title_short | IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? |
| title_sort | igf2bp1, a new target to overcome drug resistance in melanoma? |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354603/ https://www.ncbi.nlm.nih.gov/pubmed/35935853 http://dx.doi.org/10.3389/fphar.2022.947363 |
| work_keys_str_mv | AT xiyufeng igf2bp1anewtargettoovercomedrugresistanceinmelanoma AT wangyujia igf2bp1anewtargettoovercomedrugresistanceinmelanoma |